Market Closed -
Other stock markets
|
After market 04:00:01 pm | |||
770 EUR | +0.33% | 768.4 | -0.20% |
03:36pm | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
01:00am | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
Evolution of the average Target Price on Eli Lilly and Company
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Eli Lilly and Company
Goldman Sachs | |
Jefferies & Co. | |
Argus | |
Redburn Atlantic | |
China International Capital | |
JPMorgan Chase | |
Wolfe Research | |
Barclays | |
BMO Capital | |
Leerink Partners | |
Deutsche Bank Securities | |
Truist Securities | |
Wells Fargo Securities | |
Morgan Stanley | |
UBS | |
BofA Securities | |
DZ Bank | |
JEFFERIES | Akash Tewari |
Cantor Fitzgerald | |
Morningstar | |
Guggenheim | |
Daiwa Securities | |
Berenberg Bank | |
Citigroup | |
Credit Suisse | |
HSBC | |
TD Cowen | |
SVB Securities LLC | |
Cowen | |
Mizuho Securities |
EPS Revisions
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- Consensus Eli Lilly and Company